Smad7 knockdown restores aryl hydrocarbon receptor-mediated protective signals in the gut

Journal of Crohn's and Colitis

Volumn 10, Issue 6, 2016, Pages 670-677

  Monteleone, Ivan ^a   Marafini, Irene ^a   Zorzi, Francesca ^a   Di Fusco, Davide ^a   Dinallo, Vincenzo ^a   Rizzo, Angela ^a   Sileri, Pierpaolo ^a   Sica, Giuseppe ^a   Monteleone, Giovanni ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Colitis; Crohn's disease; Ficz; Inflammation; Intestine; TGF

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; AROMATIC HYDROCARBON RECEPTOR; CARBAZOLE DERIVATIVE; CORTICOSTEROID; INFLIXIMAB; INTERLEUKIN 22; MESALAZINE; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; 6-FORMYLINDOLO(3,2-B)CARBAZOLE; AHR PROTEIN, HUMAN; AHR PROTEIN, MOUSE; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; SMAD7 PROTEIN, HUMAN; SMAD7 PROTEIN, MOUSE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; HUMAN; INTESTINE; INTESTINE RESECTION; LAMINA PROPRIA; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAG1-/- MOUSE; T LYMPHOCYTE; TRANSGENIC MOUSE; ANIMAL; C57BL MOUSE; CASE CONTROL STUDY; DEFICIENCY; FEMALE; GENE SILENCING; GENETICS; ILEUM; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; MIDDLE AGED;

ADULT; AGED; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARBAZOLES; CASE-CONTROL STUDIES; COLITIS; CROHN DISEASE; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; ILEUM; INTERLEUKINS; INTESTINAL MUCOSA; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIDDLE AGED; RECEPTORS, ARYL HYDROCARBON; SMAD7 PROTEIN; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84985000707     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jjw030     Document Type: Article

References (41)

1. MacDonald TT, Monteleone I, Fantini MC, Monteleone G. Regulation of homeostasis and inflammation in the intestine. Gastroenterology 2011;140:1768-75.
2. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol 2010;28:573-621.
3. Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol 2014;14:329-42.
4. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: Clinical aspects and established and evolving therapies. Lancet 2007;369:1641-57.
5. de Souza HS, Fiocchi C. Immunopathogenesis of IBD: Current state of the art. Nat Rev Gastroenterol Hepatol 2016;13:13-27.
6. Danese S. New therapies for inflammatory bowel disease: From the bench to the bedside. Gut 2012;61:918-32.
7. Gu YZ, Hogenesch JB, Bradfield CA. The pas superfamily: Sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 2000;40:519-61.
8. Rannug U, Rannug A, Sjoberg U, et al. Structure elucidation of two tryptophan-derived, high affinity AH receptor ligands. Chem Biol 1995;2:841-5.
9. Denison MS, Nagy SR. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 2003;43:309-34.
10. Veldhoen M, Hirota K, Westendorf AM, et al. The aryl hydrocarbon receptor links th17-cell-mediated autoimmunity to environmental toxins. Nature 2008;453:106-9.
11. Quintana FJ, Basso AS, Iglesias AH, et al. Control of T[reg] and T[h]17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008;453:65-71.
12. Zhang L, Ma J, Takeuchi M, et al. Activation of aryl hydrocarbon receptor suppresses experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells. Invest Ophthalmol Vis Sci 2010;51:2109-17.
13. Gandhi R, Kumar D, Burns EJ, et al. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and foxp3[+] regulatory T cells. Nat Immunol 2010;11:846-53.
14. Apetoh L, Quintana FJ, Pot C, et al. The aryl hydrocarbon receptor interacts with c-maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat Immunol 2010;11:854-61.
15. Nguyen NT, Kimura A, Nakahama T, et al. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynureninedependent mechanism. Proc Natl Acad Sci U S A 2010;107:19961-6.
16. Quintana FJ, Murugaiyan G, Farez MF, et al. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2010;107:20768-73.
17. Monteleone I, Rizzo A, Sarra M, et al. Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology 2011;141:237-48 e1.
18. Huang Z, Jiang Y, Yang Y, et al. 3,3'-diindolylmethane alleviates oxazolone-induced colitis through th2/th17 suppression and Treg induction. Mol Immunol 2012;53:335-44.
19. Singh NP, Singh UP, Singh B, et al. Activation of aryl hydrocarbon receptor [AHR] leads to reciprocal epigenetic regulation of foxp3 and IL-17 expression and amelioration of experimental colitis. PLoS One 2011;6:e23522.
20. Monteleone G, Kumberova A, Croft NM, et al. Blocking smad7 restores TGF-beta1 signalling in chronic inflammatory bowel disease. J Clin Invest 2001;108:601-9.
21. Monteleone G, Biancone L, Marasco R, et al. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 1997;112:1169-78.
22. Fantini MC, Rizzo A, Fina D, et al. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression. Gastroenterology 2009;136:1308-16, e13.
23. Boirivant M, Pallone F, Di Giacinto C, et al. Inhibition of smad7 with a specific antisense oligonucleotide facilitates TGF-beta1-mediated suppression of colitis. Gastroenterology 2006;131:1786-98.
24. Alam MS, Maekawa Y, Kitamura A, et al. Notch signalling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A 2010;107:59438.
25. Sugimoto K, Ogawa A, Mizoguchi E, et al. Il-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 2008;118:534-44.
26. Zenewicz LA, Yancopoulos GD, Valenzuela DM, et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008;29:947-57.
27. Monteleone I, Pallone F, Monteleone G. Aryl hydrocarbon receptor and colitis. Semin Immunopathol 2013;35:671-5.
28. Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995;182:1281-90.
29. Neurath MF, Weigmann B, Finotto S, et al. The transcription factor t-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med 2002;195:1129-43.
30. Elson CO, Cong Y, Weaver CT, et al. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 2007;132:2359-70.
31. Furumatsu K, Nishiumi S, Kawano Y, et al. A role of the aryl hydrocarbon receptor in attenuation of colitis. Dig Dis Sci 2011;56:2532-44.
32. Takamura T, Harama D, Matsuoka S, et al. Activation of the aryl hydrocarbon receptor pathway may ameliorate dextran sodium sulfate-induced colitis in mice. Immunol Cell Biol 2010;88:685-9.
33. Gagliani N, Vesely MC, Iseppon A, et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 2015;523:221-5.
34. Mezrich JD, Fechner JH, Zhang X, et al. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol 2010;185:3190-8.
35. Bellemore SM, Nikoopour E, Schwartz JA, et al. Preventative role of interleukin-17 producing regulatory T helper type 17 [Treg 17] cells in type 1 diabetes in non-obese diabetic mice. Clin Exp Immunol 2015;182:2619.
36. Derynck R, Zhang YE. Smad-dependent and smad-independent pathways in TGF-beta family signalling. Nature 2003;425:577-84.
37. Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45rb[low] CD4+ T cells. J Exp Med 1996;183:2669-74.
38. Gorelik L, Fields PE, Flavell RA. Cutting edge: TGF-beta inhibits th type 2 development through inhibition of gata-3 expression. J Immunol 2000;165:4773-7.
39. Monteleone G, Boirivant M, Pallone F, MacDonald TT. TGF-beta1 and smad7 in the regulation of IBD. Mucosal Immunol 2008;1[Suppl 1]:S50-3.
40. Neurath MF, Fuss I, Kelsall BL, et al. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med 1996;183:2605-16.
41. Monteleone G, Neurath MF, Ardizzone S, et al. Mongersen, an oral smad7 antisense oligonucleotide, and Crohn's disease. N Engl J Med 2015;372:1104-13.